HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Top Cited Papers
- 6 August 2004
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 305 (5685) , 872-874
- https://doi.org/10.1126/science.1097670
Abstract
Natural killer (NK) cells provide a central defense against viral infection by using inhibitory and activation receptors for major histocompatibility complex class I molecules as a means of controlling their activity. We show that genes encoding the inhibitory NK cell receptor KIR2DL3 and its human leukocyte antigen C group 1 (HLA-C1) ligand directly influence resolution of hepatitis C virus (HCV) infection. This effect was observed in Caucasians and African Americans with expected low infectious doses of HCV but not in those with high-dose exposure, in whom the innate immune response is likely overwhelmed. The data strongly suggest that inhibitory NK cell interactions are important in determining antiviral immunity and that diminished inhibitory responses confer protection against HCV.Keywords
This publication has 22 references indexed in Scilit:
- In search of the ‘missing self’: MHC molecules and NK cell recognitionPublished by Elsevier ,2003
- Natural killer cell activation in mice and men: different triggers for similar weapons?Nature Immunology, 2002
- Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDSNature Genetics, 2002
- Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell ReceptorsScience, 2002
- HLA-Cw*04 and Hepatitis C Virus PersistenceJournal of Virology, 2002
- Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope ProteinThe Journal of Experimental Medicine, 2001
- Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICAScience, 1999
- Hepatitis C virus RNA in factor VIII concentratesTransfusion, 1995
- Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug usersThe Lancet, 1990
- Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategyNature, 1986